Related Experiment Videos
Beta-adrenergic blocking drugs in the management of hypertension
1Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.
American journal of hypertension·1999
Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation·1998
End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy.
Archives of internal medicine·1998
Parenteral hydralazine revisited.
The Journal of emergency medicine·1998
Comparative effects of nabumetone, sulindac, and ibuprofen on renal function.
The Journal of rheumatology·1997
Dominantly transmitted glomerulocystic kidney disease: a distinct genetic entity.
Journal of the American Society of Nephrology : JASN·1997
Heparin-induced thrombocytopenia and thrombosis.
Comprehensive therapy·2011
Antiplatelet therapy in cardiovascular disease.
Comprehensive therapy·2011
Genetics of cardiovascular disease.
Comprehensive therapy·2011
Septic renal vein thrombosis complicated by septic pulmonary embolism.
Comprehensive therapy·2011
Gout and hyperuricemia.
Comprehensive therapy·2011
Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Comprehensive therapy·2010
Oral PCSK9 inhibitors: closing the gap between potency and practicality.
Current opinion in lipidology·2026
SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.
Journal of bone metabolism·2026
Public funding for paediatric medications in Canada.
Paediatrics & child health·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026